Real-life long-term efficacy of dupilumab in adults with moderate to severe atopic dermatitis: Results of a cohort study

Ann Dermatol Venereol. 2023 Sep;150(3):215-216. doi: 10.1016/j.annder.2023.06.004. Epub 2023 Aug 17.

¹ Department of Dermatology, CHU and Université de Toulouse, Toulouse, France. Electronic address: guedon.c@chu-toulouse.fr.
² Department of Dermatology, CHU Lyon, Lyon, France.
³ Department of Dermatology, CH Pau, Pau, France.
⁴ Department of Dermatology, CHU and Université de Toulouse, Toulouse, France.
⁵ Department of Epidemiology, Clinical Epidemiology and Public Health, UMR 1027 INSERM-University of Toulouse III, Toulouse University Hospital (CHU), Toulouse, France.

No abstract available

Keywords: Atopic dermatitis; Dupilumab; Long-term efficacy; Real-world.

MeSH terms